|
ACRS Aclaris Therapeutics Inc 1557746 |
| Balance Sheet |
|
Current Assets
|
$110,230,000.00 |
|
Assets
|
$198,720,000.00 |
|
Current Liabilities
|
$27,370,000.00 |
|
Liabilities
|
$55,071,000.00 |
|
Equity
|
$143,649,000.00 |
|
Shares Out
|
139652849.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,149,000.00 |
|
Investing Cash Flow
|
$-30,932,000.00 |
| Market Analysis |
Market Cap
|
$742,953,156.68 |
|
Price
|
$5.07 |
|
BVPS
|
1.03 |
|
PB
|
5.17 |
|
EPS
|
-0.15 |
|
PS
|
97.25 |
|
FCF
|
$-18,162,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.16 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.15 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.13 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.12 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACRS documents filed with the SEC.
ACRS Filings
Clear
